<?xml version="1.0" encoding="UTF-8"?>
<p>Our results highlight that the home care of AATD patients, who need augmentation therapy, contributes to the optimal care and improvement of the patients' quality of life. Again, a home-based administration is safe and demonstrates no side effects. According to the results of other studies, home care is also practicable for several years (
 <xref rid="B12" ref-type="bibr">Wilke et al., 2018</xref>). Limitations of the study are the use of a reduced version of the SGRQ currently not validated and the small number of patients. In our study, we took advantage of a free patient support program to allow patients to continue therapy at home, the cost of the specific patient support program were fully bore by Grifols Italy. Consequently, the costs for the public health system were zero. However, due to the little diffusion of home therapy, to date, there are no studies that compare the cost of the hospital with home assistance.
</p>
